Pemphigus herpetiformis with an autoimmune response to recombinant desmoglein 1.
Seitz
C S
CS
Staegemeir
E
E
Amagai
M
M
Rose
C
C
Bröcker
E B
EB
Zillikens
D
D
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003598:Cytoskeletal Proteins / Q000276:immunology*; D051183:Desmoglein 1; D051182:Desmogleins; D051180:Desmoplakins; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010392:Pemphigus / Q000188:drug therapy / Q000276:immunology*
D000893:Anti-Inflammatory Agents; D001323:Autoantibodies; D003598:Cytoskeletal Proteins; C495297:DSG1 protein, human; D051183:Desmoglein 1; D051182:Desmogleins; D051180:Desmoplakins; D007166:Immunosuppressive Agents; D003907:Dexamethasone; D003520:Cyclophosphamide